Skip to content
OpenCapital
Get started

National Healthcare NHC EV / sales

EV / sales at other companies

Encompass Health Corporation logo
Encompass Health CorporationEHC
2.1×-0.3×
The Ensign Group logo
The Ensign GroupENSG
2.5×+0.5×
Brookdale Senior Living logo
Brookdale Senior LivingBKD
2.7×+0.6×
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
0.9×-0.4×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.7×+0.2×
HCA Healthcare logo
HCA HealthcareHCA
2×+0.2×

Other financials

Income statement

See full
Revenue$381.8M+2.2%
Net income$36.1M+11.8%

Balance sheet

See full
Cash & equivalents$85.5M-5.4%
Total debt$39.3M-80.6%
Total equity$1.1B+8.6%
Total assets$1.5B-1.6%

Cash flow

See full
Operating cash flow$62.5M+59.3%
CapEx$9.6M+57.1%
Free cash flow$52.9M+59.7%

Valuation

See full
Market cap$3.12B+73.0%
Enterprise value$3.07B+57.4%
P/E24.7×+8.0×
P/S2×+0.7×

Profitability

See full
Net margin8.3%+0.5pp
FCF margin11%+3.2pp

Returns & leverage

See full
Return on equity12.1%+0.9pp
Debt / equity0×-0.2×
Current ratio1.9×0.0×

Where this comes from

Calculated from National Healthcare’s reported figures.

enterprise value/total revenue=1.6×

Based on the most recent quarter.

The official record: National Healthcare’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Healthcare's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is National Healthcare's EV / sales?
National Healthcare (NHC) reported EV / sales of 1.6× in Q1 2026.
How has National Healthcare's EV / sales changed year-over-year?
National Healthcare's EV / sales increased by 42.8% year-over-year, from 1.1× to 1.6×.
What is the long-term trend for National Healthcare's EV / sales?
Over 5 years (2020 to 2025), National Healthcare's EV / sales has grown at a 6.1% compound annual growth rate (CAGR), from 1× to 1.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.